Salivary calprotectin and neutrophils in inflammatory bowel disease in relation to oral diseases
Oral Diseases · 2025
DOI: 10.1111/odi.15036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Mirjam Majster und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oral Diagnostics and Rehabilitation, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Leukocyte L1 Antigen Complex, Neutrophils, Saliva, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Region Stockholm, The Center for Innovative Medicine (CIMED), The Ihre Foundation.
Abstract (Originalsprache)
Objective
Calprotectin is elevated in saliva from inflammatory bowel disease (IBD) patients, but it is also affected by oral disease. We assessed the salivary concentration of calprotectin in IBD patients, in relation to intestinal and oral diseases. Furthermore, we investigated the phenotype of salivary neutrophils from IBD patients, and their ability to secrete calprotectin. Materials and Methods Thirty IBD patients and 26 controls were orally examined and sampled for stimulated saliva. Twenty‐five IBD patients provided fresh fecal samples. Calprotectin concentrations in saliva and feces were determined by an enzyme‐linked immunosorbent assay. Expression of CD11b, CD15, and CD16 on oral neutrophils was assessed by flow cytometry. Secretion of calprotectin was evaluated in cultured oral neutrophils.
Results
Calprotectin was significantly elevated in saliva of IBD patients compared to controls, particularly in Crohn's disease, irrespective of caries or periodontitis. Salivary calprotectin did not correlate to fecal calprotectin. CD11b expression was significantly reduced in salivary neutrophils from IBD patients. Salivary neutrophils from IBD patients tended to secrete more calprotectin than controls.
Conclusions
Salivary calprotectin is elevated in IBD regardless of oral diseases. Furthermore, salivary neutrophils secrete calprotectin, and display lower CD11b expression in IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Oral Diagnostics and Rehabilitation, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
- Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
- Division of Gastroenterology, Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
- Division of Oral Diseases, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden.
- Department of Orofacial Medicine, Folktandvården Stockholms Län AB, Stockholm, Sweden.
ORCID-Profile: Elisabeth Almer Boström
Förderung
- Region Stockholm
- The Center for Innovative Medicine (CIMED)
- The Ihre Foundation
- Thuréus Foundation
- The Patent Revenue Fund for Research in Preventive Odontology
- Karolinska Institutet Foundations
- Swedish Dental Society
- Center for Innovative Medicine
Zitieren
APA
Majster, M., Almer, S., Malmqvist, S., Johannsen, A., Lira-Junior, R., & Boström, E. A. (2025). Salivary calprotectin and neutrophils in inflammatory bowel disease in relation to oral diseases. Oral Diseases. https://doi.org/10.1111/odi.15036
Vancouver
Majster M, Almer S, Malmqvist S, Johannsen A, Lira-Junior R, Boström EA. Salivary calprotectin and neutrophils in inflammatory bowel disease in relation to oral diseases. Oral Diseases. 2025. doi:10.1111/odi.15036
BibTeX
@article{Majster2025,
author = {Majster, Mirjam and Almer, Sven and Malmqvist, Sebastian and Johannsen, Annsofi and Lira-Junior, Ronaldo and Boström, Elisabeth Almer},
title = {Salivary calprotectin and neutrophils in inflammatory bowel disease in relation to oral diseases},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.15036}
}
EUVIMED